ZEB2 and cancer: Additionally, RING1B has also been shown to promote EMT and metastatic progression of cancer cells by activating the expression of ZEB2 and inhibiting the expression of E-cadherin, further demonstrating its important role in cancer development (Figure 4D) [24,122].